Compound information
- Natural Products
- ZC927393
- Molecular Formula
- C16H24N2O4S
- Molecular Weight
- 340.145678248 g/mol
- Structure
-
- IUPAC Name
- methyl 4-(4-tert-butylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C16H24N2O4S/c1-16(2,3)13-5-7-14(8-6-13)23(20,21)18-11-9-17(10-12-18)15(19)22-4/h5-8H,9-12H2,1-4H3
- InChI Key
- QEYVFCBUJMPIGH-UHFFFAOYSA-N
- SMILES
- COC(=O)N1CCN(S(=O)(=O)c2ccc(C(C)(C)C)cc2)CC1
- Source
- ZINC000012381746
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 2.893 |
LogS | -3.591 | LogD | 3.043 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.078 | Pgp substrate | 0.984 |
HIA | 0.959 | F20 % | 0.832 |
F30 % | 0.893 | Caco-2 | -4.456 |
MDCK | -4.88 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.266 | PPB | 96.541 |
VD | 1.489 | Fu | 0.542 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.121 | CYP1A2 substrate | 0.339 |
CYP2A6 substrate | 0.485 | CYP2B6 substrate | 0.615 |
CYP2C19 inhibitor | 0.882 | CYP2C19 substrate | 0.636 |
CYP2C8 substrate | 0.547 | CYP2C9 inhibitor | 0.385 |
CYP2C9 substrate | 0.99 | CYP2D6 inhibitor | 0.08 |
CYP2D6 substrate | 0.446 | CYP2E1 substrate | 0.362 |
CYP3A4 inhibitor | 0.1 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.293 | CL | 6.685 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.675 | Hepatotoxicity | 0.926 |
Mutagenicity | 0.18 | Rat Oral Acute Toxicity | 0.292 |
FDAMDD | 0.768 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.867 | Eye Corrosion | 0.022 |
Eye Irritation | 0.074 | Respiratory Toxicity | 0.755 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.631 | IGC50 | 3.23 |
LC50FM | 2.528 | LC50DM | 4.116 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.299 | NR-AR-LBD | 0.273 |
NR-AhR | 0.025 | NR-Aromatase | 0.239 |
NR-ER | 0.247 | NR-ER-LBD | 0.372 |
NR-PPAR-gamma | 0.141 | SR-ARE | 0.615 |
SR-ATAD5 | 0.393 | SR-HSE | 0.072 |
SR-MMP | 0.025 | SR-p53 | 0.027 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.